CRMD
CorMedix Inc (CRMD)
Healthcare • NASDAQ • $7.920.00%
- Symbol
- CRMD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $7.92
- Daily Change
- 0.00%
- Market Cap
- $621.26M
- Trailing P/E
- 3.88
- Forward P/E
- 11.00
- 52W High
- $17.43
- 52W Low
- $6.13
- Analyst Target
- $15.00
- Dividend Yield
- N/A
- Beta
- 1.46
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Company websiteResearch CRMD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.